Overexpression of COX7A1 Promotes the Resistance of Gastric Cancer to Oxaliplatin and Weakens the Efficacy of Immunotherapy.

MLA

Wang, Si-Yu, et al. “Overexpression of COX7A1 Promotes the Resistance of Gastric Cancer to Oxaliplatin and Weakens the Efficacy of Immunotherapy.” Laboratory Investigation (00236837), vol. 104, no. 8, Aug. 2024, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.labinv.2024.102090.

APA

Wang, S.-Y., Yang, X.-Q., Wang, Y.-X., Shen, A., Liang, C.-C., Huang, R.-J., Cheng, U. H., Jian, R., An, N., Xiao, Y.-L., Wang, L.-S., Zhao, Y., Lin, C., Wang, C.-P., Yuan, Z.-P., & Yuan, S.-Q. (2024). Overexpression of COX7A1 Promotes the Resistance of Gastric Cancer to Oxaliplatin and Weakens the Efficacy of Immunotherapy. Laboratory Investigation (00236837), 104(8), N.PAG. https://doi.org/10.1016/j.labinv.2024.102090

Chicago

Wang, Si-Yu, Xian-Qi Yang, Yu-Xin Wang, Ao Shen, Cheng-Cai Liang, Run-Jie Huang, Un Hio Cheng, et al. 2024. “Overexpression of COX7A1 Promotes the Resistance of Gastric Cancer to Oxaliplatin and Weakens the Efficacy of Immunotherapy.” Laboratory Investigation (00236837) 104 (8): N.PAG. doi:10.1016/j.labinv.2024.102090.